Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel route for Gemcitabine HCl with high yield and purity. Reduces steps and improves scalability for API manufacturing.
Patent CN1671669A details a high-purity celecoxib synthesis route reducing regioisomers via controlled water and acid catalysis for cost-effective manufacturing.
Advanced patent CN107033210A details a high-yield Fulvestrant route. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN1671669A details a high-purity celecoxib synthesis method reducing regioisomers via controlled water and acid catalysis for cost-effective manufacturing.
Patent CN108101830B details a metal-free oxidation route for oxindoles, offering cost reduction in API manufacturing and high-purity intermediates.
Patent CN107573276A reveals NHC-catalyzed indolinone synthesis. High yield, mild conditions offer cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel mild preparation of antineoplastic drug tegafur using 2-benzoyloxy tetrahydrofuran. High yield, >99.7% purity, scalable industrial process.
Patent CN117924403B details a low-toxicity synthesis route for sodium carbenoxolone using toluene and DMAP, ensuring high purity and cost efficiency for pharmaceutical supply chains.
Novel synthetic method for Parecoxib Sodium Impurity I ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN119118862B reveals one-step agomelatine synthesis reducing complexity. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN117886789A reveals efficient Ir-catalyzed synthesis. Offers high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability for global buyers.
Novel reductive amination route for influenza inhibitor intermediate. High yield, safe scale-up, and cost-effective pharmaceutical manufacturing solutions.
Patent CN112225700B reveals a novel two-step reduction process for high-purity atemezole. This method ensures mild conditions and significant supply chain reliability for veterinary drugs.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Novel synthetic route for high-purity tylonolide offering significant yield improvements and supply chain reliability for veterinary pharmaceutical manufacturing partners.
Patent CN109134392A reveals a mild synthetic route for N2-alkenyl benzotriazoles. Achieve high selectivity and cost reduction in fine chemical manufacturing with scalable processes.
Patent CN113929587A reveals high-yield synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel sulfonation resolution method for dexmedetomidine intermediate ensures high yield and purity for pharmaceutical supply chains.
Novel one-step Lewis acid catalysis improves vinpocetin yield to 90% with >99% purity, offering significant supply chain stability and cost efficiency for global buyers.
Patent CN102718829B reveals high-yield TUDCA synthesis avoiding ion-exchange columns ensuring cost reduction and supply reliability for global pharmaceutical intermediates